Common Stock Warrants (Details Textual) (USD $)	1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 30, 2007	Sep. 30, 2012	Sep. 30, 2012	Dec. 31, 2011
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Common stock, shares issued		45,268,905	45,268,905	43,416,200
Common stock, shares outstanding		45,268,905	45,268,905	43,416,200
Warrants Granted			200,000
Common stock warrants (Textual) [Abstract]
Exercise price per share			1.43
Albitar Warrant period			5 years
Value of warrant		$ 342,500	$ 342,500
Stock compensation expense		$ 95,800	$ 128,000
Warrants Issued	348,417
Deemed value per share			$ 4.00
Warrant [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Common stock, shares issued		650,000	650,000
Plasma Prostate Cancer Test Licensed From Health Discovery Corp HDC [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrants Granted			80,000
Colon Cancer Test Licensed From HDC [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrants Granted			40,000
Pancreatic Cancer Test Licensed From HDC [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrants Granted			40,000
Cytogenetics Automated Image Analysis Technology Licenses From HDC [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrants Granted			20,000
Cytometry Automated Image Analysis Technology Licenses From HDC [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrants Granted			20,000